These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 23592668)
21. Nonalcoholic fatty liver disease among patients with hypothalamic and pituitary dysfunction. Adams LA; Feldstein A; Lindor KD; Angulo P Hepatology; 2004 Apr; 39(4):909-14. PubMed ID: 15057893 [TBL] [Abstract][Full Text] [Related]
22. Predictors of nonalcoholic steatohepatitis in patients undergoing bariatric surgery: when is liver biopsy indicated? Helling TS; Helzberg JH; Nachnani JS; Gurram K Surg Obes Relat Dis; 2008; 4(5):612-7. PubMed ID: 18226970 [TBL] [Abstract][Full Text] [Related]
23. Hepatic histology in obese patients undergoing bariatric surgery. Machado M; Marques-Vidal P; Cortez-Pinto H J Hepatol; 2006 Oct; 45(4):600-6. PubMed ID: 16899321 [TBL] [Abstract][Full Text] [Related]
24. Surgical treatment of non-alcoholic steatohepatitis and non-alcoholic fatty liver disease. Weiner RA Dig Dis; 2010; 28(1):274-9. PubMed ID: 20460923 [TBL] [Abstract][Full Text] [Related]
25. Patterns of surgical weight loss and resolution of metabolic abnormalities in superobese bariatric adolescents. Holterman AX; Holterman M; Browne A; Henriques S; Guzman G; Fantuzzi G J Pediatr Surg; 2012 Sep; 47(9):1633-9. PubMed ID: 22974598 [TBL] [Abstract][Full Text] [Related]
26. Retinol-binding protein 4: a promising circulating marker of liver damage in pediatric nonalcoholic fatty liver disease. Nobili V; Alkhouri N; Alisi A; Ottino S; Lopez R; Manco M; Feldstein AE Clin Gastroenterol Hepatol; 2009 May; 7(5):575-9. PubMed ID: 19268270 [TBL] [Abstract][Full Text] [Related]
27. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes. Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941 [TBL] [Abstract][Full Text] [Related]
28. Laparoscopic bariatric surgery: what else are we uncovering? Liver pathology and preoperative indicators of advanced liver disease in morbidly obese patients. Kroh M; Liu R; Chand B Surg Endosc; 2007 Nov; 21(11):1957-60. PubMed ID: 17479322 [TBL] [Abstract][Full Text] [Related]
29. [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease]. Fan JG; Zhou Q; Wo QH Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):676-9. PubMed ID: 20943079 [TBL] [Abstract][Full Text] [Related]
30. Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years. Wong VW; Wong GL; Choi PC; Chan AW; Li MK; Chan HY; Chim AM; Yu J; Sung JJ; Chan HL Gut; 2010 Jul; 59(7):969-74. PubMed ID: 20581244 [TBL] [Abstract][Full Text] [Related]
31. Liver damage in severely obese patients: a clinical-biochemical-morphologic study on 1,000 liver biopsies. Papadia FS; Marinari GM; Camerini G; Murelli F; Carlini F; Stabilini C; Scopinaro N Obes Surg; 2004 Aug; 14(7):952-8. PubMed ID: 15329185 [TBL] [Abstract][Full Text] [Related]
32. Liver visfatin expression in morbidly obese patients with nonalcoholic fatty liver disease undergoing bariatric surgery. Kukla M; Ciupińska-Kajor M; Kajor M; Wyleżoł M; Żwirska-Korczala K; Hartleb M; Berdowska A; Mazur W Pol J Pathol; 2010; 61(3):147-53. PubMed ID: 21225497 [TBL] [Abstract][Full Text] [Related]
33. The prevalence of nonalcoholic steatohepatitis is greater in morbidly obese men compared to women. Arun J; Clements RH; Lazenby AJ; Leeth RR; Abrams GA Obes Surg; 2006 Oct; 16(10):1351-8. PubMed ID: 17059746 [TBL] [Abstract][Full Text] [Related]
34. The severity of histologic liver lesions is independent of body mass index in patients with nonalcoholic fatty liver disease. Margariti A; Deutsch M; Manolakopoulos S; Tiniakos D; Papatheodoridis GV J Clin Gastroenterol; 2013 Mar; 47(3):280-6. PubMed ID: 23391869 [TBL] [Abstract][Full Text] [Related]
35. Intragastric balloon significantly improves nonalcoholic fatty liver disease activity score in obese patients with nonalcoholic steatohepatitis: a pilot study. Lee YM; Low HC; Lim LG; Dan YY; Aung MO; Cheng CL; Wee A; Lim SG; Ho KY Gastrointest Endosc; 2012 Oct; 76(4):756-60. PubMed ID: 22840293 [TBL] [Abstract][Full Text] [Related]
37. Noninvasive clinical model for the diagnosis of nonalcoholic steatohepatitis in overweight and morbidly obese patients undergoing bariatric surgery. Pirvulescu I; Gheorghe L; Csiki I; Becheanu G; Dumbravă M; Fica S; Martin S; Sarbu A; Gheorghe C; Diculescu M; Copăescu C Chirurgia (Bucur); 2012; 107(6):772-9. PubMed ID: 23294957 [TBL] [Abstract][Full Text] [Related]
38. Steatohepatitic hepatocellular carcinoma (SH-HCC): a distinctive histological variant of HCC in hepatitis C virus-related cirrhosis with associated NAFLD/NASH. Salomao M; Yu WM; Brown RS; Emond JC; Lefkowitch JH Am J Surg Pathol; 2010 Nov; 34(11):1630-6. PubMed ID: 20975341 [TBL] [Abstract][Full Text] [Related]
39. Obstructive sleep apnea, insulin resistance, and steatohepatitis in severe obesity. Polotsky VY; Patil SP; Savransky V; Laffan A; Fonti S; Frame LA; Steele KE; Schweizter MA; Clark JM; Torbenson MS; Schwartz AR Am J Respir Crit Care Med; 2009 Feb; 179(3):228-34. PubMed ID: 18990675 [TBL] [Abstract][Full Text] [Related]
40. Nonalcoholic fatty liver disease and bariatric surgery in adolescents. Holterman A; Gurria J; Tanpure S; DiSomma N Semin Pediatr Surg; 2014 Feb; 23(1):49-57. PubMed ID: 24491369 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]